The identified GRP78‐specific peptide, including WDLAWMFRLPVG and WIFPWIQL, were applied for targeted delivery of cytotoxic agents to tumor cells that overexpressed GRP78, such as PCs.386. Here, HSPA5 is linked to neoplasm.